CMAC's Digital Medicines Manufacturing
March 21, 2023
March 21st, 3.30pm (GMT)
"From particles to drug product performance and stability"
Interesting news to share with the community?
Carried a new study out?
This newsfeed is yours, do not hesitate!
MySTYL'One
March 17, 2023
MySTYL'One user exclusive!
This new bulletin available details a study on a compaction characterisation from a combined formulation of Piroxicam amorphous solid dispersionns and Kollitab™ DC 87 L.
#Amorphous Solid Dispersion #KTab #Characterisation #compaction simulator #STYL'One Nano
Cambrex
March 16, 2023
Pharmaceutical companies are looking to pediatric indications of approved adult dosage forms (ADFs) to sustain and fuel growth. The desire to develop pediatric dosage forms (PDFs) of drugs with existing adult indications has two main drivers: (1) the US Food and Drug Administration’s (FDA’s) role in limiting off-label use in pediatric patients, which aligns with the FDA’s role in ensuring the safety and efficacy of approved products for all patients; and (2) sustaining revenue growth through ...
Pharmaceutical companies are looking to pediatric indications
of approved adult dosage forms (ADFs) to sustain and fuel
growth. The desire to develop pediatric dosage forms (PDFs)
of drugs with existing adult indications has two main drivers: (1)
the US Food and Drug Administration’s (FDA’s) role in limiting
off-label use in pediatric patients, which aligns with the FDA’s
role in ensuring the safety and efficacy of approved products for
all patients; and (2) sustaining revenue growth through pediatric
exclusivity that typically adds 180 days of intellectual property
protection and thus almost 6 additional months of branded drug
sales, which in some cases could translate to billions of dollars in
revenue.
#scale-up #manufacturing #pediatric drug development #dosage form
MySTYL'One
March 13, 2023
In this paper you will find a study that focuses on the assessment of the capping problem using computer modelling of the pharmaceutical powder compression and consolidation process using the finite element analysis (FEA) method implementing the Drucker–Prager Cap (DPC) model. The paper is available in the PAPERS section.
Find others papers here and learn about
In this paper you will find a study that focuses on the assessment of the capping problem using computer modelling of the pharmaceutical powder compression and consolidation process using the finite element analysis (FEA) method implementing the Drucker–Prager Cap (DPC) model. The paper is available in the PAPERS section.
Find others papers here and learn about
#STYL'One #Powder compaction #Drucker-Prager Cap model #capping
Korsch AG
March 6, 2023
KORSCH AG, the global leader in tablet press technology, offering solutions for product development, scale-up, high-speed production, multi-layer, continuous manufacturing, and high-containment applications – has announced the acquisition of MEDELPHARM, the innovator and global leader in compaction simulator technology.
MySTYL'One
March 2, 2023
Get access for this online event replay.
Date: Tuesday, February 28th, 2023
Time: 3pm (Paris time)
Duration: 60 minutes
"Assessing temperature influence on tablet quality attributes - Using a temperature-controlled die on the STYL’One Evo compaction simulator" - by Hanna Grumann, PhD student at the Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University Düsseldorf, Germany under the supervision of Prof. Peter Kleinebudde.
#STYL'One evo #compaction simulator #sticking #picking #temperature influence #webinar
Parmaceutical manufacturer
Feb. 27, 2023
Dr. Klaus Pollinger and Dr. Martina Breuer, Aenova Group, explore the challenges of development and commercial manufacturing of oral solid dosage forms, from a CDMO perspective.
#HPAPI #CDMO #manufacturing #Solid dosage forms #R&D #production
Alix Software
Feb. 24, 2023
MySTYL'One members exclusive!
Here is your Tutorial session for a better understanding of new features on Alix Software.
MySTYL'One
Feb. 20, 2023
MySTYL'One user exclusive!
This new bulletin available details a study on an optimization of the tablet compression process of an immediate-release analgesic formulation.
#analgesic formulation #compression properties #STYL'One #process
Parmaceutical Networking
Feb. 20, 2023
MEDELPHARM’s series of STYL’One tableting instruments provides a range of solutions to industry needs for containment and isolation to provide regulatory compliant levels of operator protection when working with highly potent active pharmaceutical ingredients (HPAPIs).
The need for effective containment solutions has become ever more pressing as increasing focus on small and large molecule synthesis create new classes of high toxicity HPAPIs, with consequent shift in emphasis from protection of the molecule from cross contamination or deviation from process to prioritization of protection of the environment and workers from contamination by the molecule.